← BackOMEROS CORP · DrugmakersOMER
Elevated riskNext report: Around Nov 12 (est.)
The short versionA company. Institutions are adding.
Money moves
- No insider buying or selling in the last 30 days
- Institutions added 17% to their holdings in the quarter ending June 2026 (102 bought, 66 sold)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$16.30-1.6% that day
- Company value
- $1.2B
- Share price times all shares
- Price vs profit (P/E)
- 9.5x
- You pay about $9 for each $1 of yearly profit
- Cash vs value
- 0%
- Cash as a share of company value
From OMER's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sep '23Tap a barJun '26
Latest quarter
Quarter ended Jun 30, 2026- Revenue
- $28.5M
- EPS
- $0.15
- vs -$0.43
- Op. margin
- 0.3%
- Gross margin
- 97.2%
- Free cash flow
- $4.1M
- Share count
- +53.0%
- vs a year ago
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trendNo trades to chart yet.
Filing buzz
Last 7 days vs normal
0/ 100
- This week
- 0
- Normal week
- 1.9
- vs normal
- 0.0x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
▲Accumulating+16.9%Institutions added 16.9% to their holdings. 102 bought, 66 sold.
Shares held by institutions36.2M
Sep '24Jun '26
Share count growthYearly rate, last 3 years
+4.8%Cash runwayAt last year's cash burn
0 monthsDebt to equityLatest balance sheet: debt compared with what owners have
Owes more than it ownsShares outstandingLatest reported
72MWhy elevated risk- Losing money
- Less than a month of cash left at its current burn
- Owes more than it owns (negative equity)
- Revenue down 34% from the year before
Next reportAround Nov 12 (est.)Estimated from the same quarter last year
- Results filedAug 12
- Results filedMay 13
- Results filedMar 31
- Results filedJan 7
- Results filedNov 13, 2025
Flags and big holders
Offerings 6 months, flags 12 months, holders 90 days
No offerings, red flags or new big holders. Clean record.
Insider trades
Open-market buys and sells, last 90 days
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.
Latest filings
Straight from SEC EDGAR
SoldDavid J. BorgesVP, Finance & CAO
20,000 shares at $20.95 · $419K
- -100% of holdings
- Owns no shares after
- Pre-planned sale (10b5-1)
- 2 transactions
- Filed 1 day after trade
- Also: Option exercise
SoldPeter B CancelmoVP, General Counsel
50,000 shares at $18.59 avg ($18.54 to $18.65) · $930K
- -100% of holdings
- Now owns 200 shares
- Not a pre-planned sale
- 2 transactions
- Filed 1 day after trade
- Also: Option exercise
SoldArnold C HanishDirector
15,000 shares at $18.81 avg ($18.53 to $19.02) · $282K
- -100% of holdings
- Owns no shares after
- Not a pre-planned sale
- 3 transactions
- Filed 1 day after trade
- Also: Option exercise
SoldDavid J. BorgesVP, Finance & CAO
10,906 shares at $18.96 avg ($18.95 to $19.10) · $207K
- -100% of holdings
- Owns no shares after
- Pre-planned sale (10b5-1)
- 2 transactions
- Filed 1 day after trade
- Also: Option exercise
SoldThomas J. CableDirector
15,000 shares at $18.45 · $277K
- -30% of holdings
- Now owns 35,067 shares
- Not a pre-planned sale
- Filed 1 day after trade
- Also: Option exercise
Stock awardJoseph L SchockenDirector
30,000 shares
- Now owns 30,000 shares
- Exercise price $13.71
- Stock Option (Right to Buy)
- Filed 6 days after trade